Patents by Inventor Jabar A. FARAJ

Jabar A. FARAJ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FULVESTRANT FORMULATIONS
    Publication number: 20220143044
    Abstract: The invention provides a fulvestrant composition comprising a pharmaceutically acceptable vehicle and not more than 2% total impurities and which, optionally, is free of a non-aqueous ester solvent. The composition may be used to treat hormone receptor positive metastatic breast cancer in a subject.
    Type: Application
    Filed: December 14, 2021
    Publication date: May 12, 2022
    Applicant: Fresenius Kabi USA, LLC
    Inventor: Jabar A. FARAJ
  • Fulvestrant formulations
    Patent number: 11229655
    Abstract: The invention provides a fulvestrant composition comprising a pharmaceutically acceptable vehicle and not more than 2% total impurities and which, optionally, is free of a non-aqueous ester solvent. The composition may be used to treat hormone receptor positive metastatic breast cancer in a subject.
    Type: Grant
    Filed: January 23, 2019
    Date of Patent: January 25, 2022
    Assignee: Fresenius Kabi USA, LLC
    Inventor: Jabar A. Faraj
  • FULVESTRANT FORMULATIONS
    Publication number: 20190151333
    Abstract: The invention provides a fulvestrant composition comprising a pharmaceutically acceptable vehicle and not more than 2% total impurities and which, optionally, is free of a non-aqueous ester solvent. The composition may be used to treat hormone receptor positive metastatic breast cancer in a subject.
    Type: Application
    Filed: January 23, 2019
    Publication date: May 23, 2019
    Applicant: Fresenius Kabi USA, LLC
    Inventor: Jabar A. FARAJ
  • Fulvestrant formulations
    Patent number: 10188663
    Abstract: The invention provides a fulvestrant composition comprising not more than 2% total impurities that comprises a nonionic surfactant and/or a ricinoleate vehicle and which, optionally, is free of a non-aqueous ester solvent. The composition may be used to treat hormone receptor positive metastatic breast cancer in a subject.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: January 29, 2019
    Assignee: Fresenius Kabi USA, LLC
    Inventor: Jabar A. Faraj
  • FULVESTRANT FORMULATIONS
    Publication number: 20180050046
    Abstract: The invention provides a fulvestrant composition comprising not more than 2% total impurities that comprises a nonionic surfactant and/or a ricinoleate vehicle and which, optionally, is free of a non-aqueous ester solvent. The composition may be used to treat hormone receptor positive metastatic breast cancer in a subject.
    Type: Application
    Filed: October 31, 2017
    Publication date: February 22, 2018
    Applicant: Fresenius Kabi USA, LLC
    Inventor: Jabar A. FARAJ
  • Fulvestrant formulations
    Patent number: 9833459
    Abstract: The invention provides a fulvestrant composition comprising a pharmaceutically acceptable alcohol, polysorbate 80, an antioxidant, and castor oil, which is substantially or completely free of a non-aqueous ester solvent and which demonstrates excellent storage stability. The composition may be used to treat hormone receptor positive metastatic breast cancer in a subject.
    Type: Grant
    Filed: January 15, 2016
    Date of Patent: December 5, 2017
    Assignee: Fresenius Kabi USA, LLC
    Inventor: Jabar A. Faraj
  • FULVESTRANT FORMULATIONS
    Publication number: 20160129014
    Abstract: The invention provides a fulvestrant composition comprising a pharmaceutically acceptable alcohol, polysorbate 80, an antioxidant, and castor oil, which is substantially or completely free of a non-aqueous ester solvent and which demonstrates excellent storage stability. The composition may be used to treat hormone receptor positive metastatic breast cancer in a subject.
    Type: Application
    Filed: January 15, 2016
    Publication date: May 12, 2016
    Applicant: Fresenius Kabi USA, LLC
    Inventor: Jabar A. FARAJ
  • Fulvestrant formulations
    Patent number: 9271990
    Abstract: The invention provides a fulvestrant composition comprising a pharmaceutically acceptable alcohol, polysorbate 80, an antioxidant, and castor oil, which is substantially or completely free of a non-aqueous ester solvent and which demonstrates excellent storage stability. The composition may be used to treat hormone receptor positive metastatic breast cancer in a subject.
    Type: Grant
    Filed: February 14, 2014
    Date of Patent: March 1, 2016
    Assignee: Fresenius Kabi USA, LLC
    Inventor: Jabar A. Faraj
  • FULVESTRANT FORMULATIONS
    Publication number: 20150231153
    Abstract: The invention provides a fulvestrant composition comprising a pharmaceutically acceptable alcohol, polysorbate 80, an antioxidant, and castor oil, which is substantially or completely free of a non-aqueous ester solvent and which demonstrates excellent storage stability. The composition may be used to treat hormone receptor positive metastatic breast cancer in a subject.
    Type: Application
    Filed: February 14, 2014
    Publication date: August 20, 2015
    Inventor: Jabar A. FARAJ